AMGN has been in the news 375% more than usual
Jan 07, 2026, 7:31 PM
0.78%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen has acquired Dark Blue Therapeutics for up to $840 million to develop DBT 3757, a potential treatment for acute myeloid leukemia. This acquisition strengthens Amgen's position in precision oncology.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.